Key result
Oral polio vaccine linked to paralytic poliomyelitis in an HIV-infected child.
Why the study?
This case report aimed to describe a complication of oral vaccination with live, attenuated poliomyelitis virus in a child infected with HIV.
Does exogenous C1 esterase inhibitor reduce myocardial injury in a rat model of ischemia and reperfusion?
Case Report (n=1)
No
Does exogenous C1 esterase inhibitor reduce myocardial injury in a rat model of ischemia and reperfusion?
Exogenous C1 esterase inhibitor reduces myocardial ischemia-reperfusion injury in a rat model by blocking complement activation and reducing endothelial adhesion molecule expression.
Answers are grounded in this paper and cite their sources.
OPV may risk paralysis in HIV-infected children; leaves open live-vaccine safety questions in immunocompromised populations.
Objective To describe a complication of oral vaccination with live, attenuated poliomyelitis virus in a child infected with HIV. Design Case report. Setting Teaching hospital in Harare, Zimbabwe. Subjects A boy of 41/2 years and his mother. Main outcome measures Results of clinical and laboratory investigations. Results Two weeks after receiving the second dose of oral poliomyelitis vaccine during national immunisation days the child developed paralysis of the right leg. He had a high titre of antibodies against poliovirus type 2, as well as antibodies against HIV-1, a low CD4 count, a ratio of CD4 to CD8 count of 0.47, and hypergammaglobulinaemia. He did not have any antibodies against diphtheria, tetanus, or poliovirus types 1 and 3, although he had been given diphtheria, tetanus, and pertussis and oral polio vaccines during his first year and a booster of the diphtheria, tetanus, and pertussis vaccine at 24 months. He had no clinical symptoms of AIDS, but his mother had AIDS and tuberculosis. Conclusion Paralytic poliomyelitis in this child with HIV infection was caused by poliovirus type 2 after oral poliomyelitis vaccine.
No takes yet. Share an insight, caveat, or question.
Chitsike et al. (1999) conducted a case report in HIV-1 infection and vaccine-associated paralytic poliomyelitis (n=1). Live attenuated oral poliomyelitis vaccine was evaluated on Paralytic poliomyelitis and poliovirus type 2 antibody response. Oral poliomyelitis vaccine was associated with right leg paralytic poliomyelitis and a 1:1024 poliovirus type 2 antibody titre two weeks after the second dose in an HIV-1-infected boy.
Synapse has enriched 10 related papers. Consider them for comparative context: